NCT05699980View on ClinicalTrials.gov

Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine Consultation

CompletedOBSERVATIONAL
Enrollment

370

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

May 23, 2022

Study Completion Date

October 3, 2022

Conditions
Dermatoporosis
Trial Locations (15)

54110

Cabinet Varangéville, Varangéville

54260

Mélanie Damervalle, Longuyon

54400

Patrick Vauthier, Longwy

54450

Sophie LARUELLE, Bénaménil

55170

Stéphanie Chevalier, Ancerville

55310

Cabinet Tronville en Barrois, Tronville-en-Barrois

57330

Anais Leclerc, Hettange-Grande

Benoit Nicolas, Hettange-Grande

57570

Cédric Berbé, Cattenom

57700

Sandra Pacini, Hayange

57970

Wissam Al Shouaib, Basse-Ham

88110

Aurelie François, Raon-l'Étape

88140

Sophie Delaporte, Bulgnéville

88150

Jean-Louis Autissier, Thaon-les-Vosges

88340

Mathieu Zimmermann, Le Val-dAjol

All Listed Sponsors
collaborator

Study Director: Anne Claire Bursztejn, PHD-MD, CHU Nancy - University of Lorraine

UNKNOWN

collaborator

Study Chair: Christophe Goetz, MD, CHR Metz-Thionville - University of Lorraine

UNKNOWN

lead

University of Lorraine

OTHER